A small-molecule protein-protein interaction inhibitor of PARP1 that targets its BRCT domain

Zhenkun Na, Bo Peng, Shukie Ng, Sijun Pan, Jun Seok Lee, Han Ming Shen, Shao Q. Yao

科研成果: 期刊稿件文章同行评审

38 引用 (Scopus)

摘要

Poly(ADP-ribose)polymerase-1 (PARP1) is a BRCT-containing enzyme (BRCT = BRCA1 C-terminus) mainly involved in DNA repair and damage response and a validated target for cancer treatment. Small-molecule inhibitors that target the PARP1 catalytic domain have been actively pursued as anticancer drugs, but are potentially problematic owing to a lack of selectivity. Compounds that are capable of disrupting protein-protein interactions of PARP1 provide an alternative by inhibiting its activities with improved selectivity profiles. Herein, by establishing a high-throughput microplate-based assay suitable for screening potential PPI inhibitors of the PARP1 BRCT domain, we have discovered that (±)-gossypol, a natural product with a number of known biological activities, possesses novel PARP1 inhibitory activity both in vitro and in cancer cells and presumably acts through disruption of protein-protein interactions. As the first known cell-permeable small-molecule PPI inhibitor of PAPR1, we further established that (-)-gossypol was likely the causative agent of PARP1 inhibition by promoting the formation of a 1:2 compound/PARP1 complex by reversible formation of a covalent imine linkage.

源语言英语
页(从-至)2515-2519
页数5
期刊Angewandte Chemie - International Edition
54
8
DOI
出版状态已出版 - 16 2月 2015
已对外发布

指纹

探究 'A small-molecule protein-protein interaction inhibitor of PARP1 that targets its BRCT domain' 的科研主题。它们共同构成独一无二的指纹。

引用此